fda statement bpc-157 not approved drug and the Difference Between an Evidence Gap and a BPC-157 Just Cleared a Major

What Is Category 2 and Why Did It Matter

All products are intended for research, laboratory, and analytical use only

If a patient has those complications, then I would go straight to the GLP-1 based drug where the evidence there for improvement

Research published in the Journal of Biological Chemistry found that GHK-Cu "significantly increased gene expression of MMP-1 and MMP-2 at the lowest concentration" tested, but this relationship becomes more complex at higher levels

BPC 157 was given per-orally, in drinking water (10 g/kg or 10 ng/kg, 0.16 g/ml, or 0.16 ng/ml 12 ml/rat/day) till sacrifice, or alternatively, 10 g/kg and 10 ng/kg intraperitoneally once daily